David Garrett serves as Executive at Dipexium Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, David Garrett has executed 1 insider transactions totaling $25.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 18, 2014 involved purchasing 2,083 shares valued at $25.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 18, 2014 | DPRX | $25.0K | Purchase | 2,083 | $12.00 | Discretionary |
David Garrett currently holds 10,007 shares of Dipexium Pharmaceuticals, Inc. (DPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Garrett has been a net buyer of DPRX stock. They have purchased $25.0K and sold $0 worth of shares.
David Garrett's most recent insider trade was on Mar 18, 2014, when they purchased 2,083 shares at $12.00 per share.
Get notified when new Form 4 filings are submitted